Effects of Osteopathic Manipulative Therapy on Symptoms of Long COVID and Post-Acute Sequelae of COVID-19
Led by University of Louisville · Updated on 2025-03-19
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of an Osteopathic Manipulative Therapy OMT protocol on individuals with Long-COVID, specifically those experiencing prolonged symptoms after COVID-19 infection. This study aims to determine if the OMT protocol, which previously showed improvement in smell dysfunction related to Long-COVID, can also improve other Long-COVID symptoms. It compares the effects of receiving one versus two OMT treatments on symptom burden over an 8-week period.
Participants will be randomly assigned to either an experimental group receiving the targeted Long-COVID OMT protocol or a control group receiving a sham OMT treatment designed to mimic therapy without targeting Long-COVID areas. The experimental OMT consists of a sequence of seven specific manual techniques intended to stimulate nervous system regulation and improve lymphatic and vascular flow. The control treatment involves different OMT techniques not aimed at Long-COVID symptoms. Treatments are delivered in two consecutive weekly sessions.
During the study, participants will complete a digital symptom survey called the Symptom Burden Questionnaire for Long COVID SBQ2-LC four times at baseline before treatment, before the second treatment, one week after the second treatment, and at 8 weeks post-enrollment. Blood pressure and heart rate will be measured at each in-person treatment visit to monitor nervous system activity. Researchers will assess changes in Long-COVID symptom burden and physiological responses to understand the therapys impact over time.
CONDITIONS
Brief Title
Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
Research Team
M
Michael E Stenta, DO, Doctor of Osteopathic Medicine
R
Rebecca Lynn, DO, Doctor of Osteopathic Medicine
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
OMT Long-COVID Protocol
OMT Sham Protocol
What it is
A structured osteopathic manual therapy protocol applying rib raising, suboccipital release, thoracic inlet release, Miller pump, pedal pump, and cranial sinus effleurage techniques developed for symptoms of Long-COVID.
Manual therapy using bilateral trapezius myofascial release, Still's technique for first rib, and hamstring muscle energy, not tailored for Long-COVID physiology; used as a sham control.
Role in the trial
Serves as the experimental arm to assess whether manual techniques targeting Long-COVID physiology can reduce symptom burden.
Functions as the sham comparator, mimicking manual contact but without specific Long-COVID-focused therapy.
How it is given or performed
Participants undergo a series of manual therapeutic techniques in-person by a physician, including rib raising and cranial effleurage, based on standardized Long-COVID protocol.
Participants receive manual techniques at the same visit schedules, but techniques are not intended to influence Long-COVID-specific physiology.
Evidence status
Efficacy in Long-COVID is under active investigation; no published outcome results are available yet for this protocol.
Sham manual therapy is not expected to provide direct symptom relief and serves as a control. No clinical outcome results reported yet.
Important limitations
OMT's effectiveness in Long-COVID is not yet established. Physiologic rationale for manipulation is supported in general populations, but evidence for symptom relief specific to Long-COVID remains limited.
Sham manual therapy is not designed to treat Long-COVID symptoms and lacks physiologic rationale for symptom relief in this population.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Adults aged 18 years or older
Prior positive SARS-CoV-2 test at least 6 weeks before enrolling
At least one ongoing Long-COVID symptom affecting daily life such as shortness of breath, muscle pain, fatigue, mood changes, altered smell or taste, cognitive difficulty, or others listed in the SBQ-LC
Willingness to complete symptom surveys and attend treatment visits
You will not qualify if you...
Denial of any ongoing Long-COVID symptoms at enrollment
Fractured bones within the last 3 months
Current participation in other Long-COVID clinical trials with active interventions during this study period
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for consent and baseline survey completion
Treatment
Duration - 2 weeks
Participants receive Osteopathic Manipulative Therapy (OMT) or sham OMT to evaluate effects on Long-COVID symptoms. The treatment aims to reduce symptom burden by improving lymphatic and vascular drainage and decreasing sympathetic tone.
2 in-person visits, one each week for treatment and assessments
Follow-up
Duration - 6 weeks post-treatment
Participants complete symptom surveys and have vital signs measured to assess Long-COVID symptom changes up to 8 weeks after initial treatment.
1 electronic survey 7 days after second treatment and 1 electronic survey at 8 weeks post initial treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Safety Evaluation of Nogapendekin Alfa Inbakicept Anktiva for Adults with Long COVID
Study on Taurine Supplementation Effects on Blood Vessel Function and Upright Posture Responses in Adults with Long COVID
Study of Blood MicroRNAs and Vitamin B12 Levels in Adults with Long COVID Neurologic Symptoms Including Depression, Anxiety, and Fatigue
Testing Immunoadsorption Treatment for Autoimmune Long COVID
A Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial
In Adults Aged 18 to 65
Improving Heart Risk Assessment Using T1 Mapping and Cardiac MRI in Adults
Evaluating Pyridostigmine and Low-Dose Naltrexone for MECFS with Orthostatic Intolerance including Long COVID
Study of Exercise Rehabilitation and Mito-Q Supplement to Improve Vascular Health in Older Veterans Recovering from COVID-19
Study of Accelerated Intermittent Theta Burst Stimulation iTBS to Treat Brain Fog and Other Symptoms in Adults With Long COVID
Evaluating a Micro-choice-based Behavioral Program to Improve Multicausal Fatigue and Daily Functioning
Effects of Osteopathic Manipulative Therapy on Symptoms of Long COVID and Post-Acute Sequelae of COVID-19
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
Jerome R Lechien, Carlos M Chiesa-Estomba, Daniele R De Siati...